Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Santen Pharmaceutical

This page shows the latest Santen Pharmaceutical news and features for those working in and with pharma, biotech and healthcare.

EMA accepts Santen’s application for glaucoma treatment STN1013001

EMA accepts Santen’s application for glaucoma treatment STN1013001

The European Medicines Agency (EMA) has accepted Santen Pharmaceutical’s (Santen) marketing authorisation application (MAA) for use of STN1013001 (cationic emulsion of latanoprost 50μg/ml) for lowering of intraocular pressure (IOP) ... The patented

Latest news

  • NICE no for new eye disease drug NICE no for new eye disease drug

    NICE's preliminary recommendation has been to ask Santen Pharmaceutical for more information on Ikervis (ciclosporin) for treating severe keratitis in adults with dry eye disease which has not improved despite

  • Meeting with resistance

    Several pharmaceutical companies appear to have recently found ways of overcoming the manufacturing obstacles. ... Low-grade B-cell lymphoma; mantle cell lymphoma. Japan. Diquafosol. Diquas Ophthalmic Solution 3% (Santen Pharmaceutical).

  • Thin on the ground

    UK. Dorzolamide/timolol. Cosopt (Santen Pharmaceutical Co). Glaucoma and ocular hypertension. Japan. ... Fera Pharmaceuticals. High intraocular pressure. US. Omeprazole/sodium bicarbonate. Par Pharmaceutical Companies.

  • News in Brief, May 30, 2007

    They also did not dismiss a combination of two of the pharmaceutical industry's biggest companies. ... Japan. He has over 30 years experience within the pharmaceutical industry. Currently, Muramatsu is a non-executive director of Santen Pharmaceutical

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Deal Watch table for March 2014 Deal Watch table for March 2014

    265.3. Takeda Pharmaceutical/ Otsuka Pharmaceutical. Co-promotion. TAK-438 (vonoprazan fumarate) for acid-related diseases (NDA filed JP). ... 22. Tracon Pharmaceuticals/ Santen Pharmaceutical Co. Licence. Tracon's anti‐endoglin antibodies, including

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Luis Iglesias heads Santen EMEA Luis Iglesias heads Santen EMEA

    president and chief operating office of parent company Santen Pharmaceutical. ... Iglesias initially joined Santen in 2017 as its senior vice president, commercial EMEA and brought with him more than 25 years’ experience in pharmaceuticals in Europe

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Improving cardiovascular disease care and awareness
Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...
Virtual Patient Engagement Program: A Customer Story
Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
Humancomms for humancare?
Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...

Quick links